Perbedaan Griptha Putra Persada Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Griptha Putra Persada Tbk. diperdagangkan di Rp137 (kapitalisasi pasar 132 M, volume 24 jam 126,63 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb). Perbedaan utamanya: Brigit Biofarmaka Teknologi Tbk. lebih besar dari sisi kapitalisasi pasar, dan Griptha Putra Persada Tbk. lebih aktif diperdagangkan (126,63 jt vs 324 rb). Mana yang lebih baik tergantung tujuan investasimu.
| GRPH | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 132 M | 166,01 M |
Volume | 126,63 jt | 324 rb |
Lot | 1,27 jt | 3,24 rb |
Perputaran | — | 77,68 jt |
Harga Rata-rata | — | 239,75 |
Nilai Transaksi | — | 77,68 jt |
Harga Ekuilibrium Indikatif | — | 240 |
Volume Ekuilibrium Indikatif | — | 1 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Griptha Putra Persada Tbk (the Company), was established based on Notarial Deed No. 26 dated April 14, 2010 of Drs. Ika Slamet Riyono, S.H., notary in Kudus. The Company started its commercial operation in July 1, 2015. The Company’s immediate parent company is PT Mulia Jaya Palma and the ultimate controlling shareholder of the Company is Samuel Jeffrey Christiawan Soegeng.
Selengkapnya di halaman GRPH →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →